Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome

References

• Wu J, Chen P, Xie YG, Gong NM, Sun LL, Sun CF. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma. Pathol Oncol Res. 2015;21(3):637–642. doi:10.1007/s12253-014-9868-525466642
   PubMed Web of Science ®Google Scholar
• Kim JA, Shim JH, Kim MJ, et al. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinoma. Br J Surg. 2016;103(1):126–135. doi:10.1002/bjs.996026572697
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol. 2010;36(11):1054–1060. doi:10.1016/j.ejso.2010.08.13320846819
   PubMed Web of Science ®Google Scholar
• Zhang L, Yin X, Gan YH, et al. Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol. 2014;14:11. doi:10.1186/1471-230X-14-1124410841
   PubMed Web of Science ®Google Scholar
• Kim YK, Kim CS, Lee JM, Chung GH, Chon SB. Efficacy and safety of radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach. Eur J Radiol. 2006;60(1):100–107. doi:10.1016/j.ejrad.2006.05.00216781835
   PubMed Web of Science ®Google Scholar
• Toyoda M, Kakizaki S, Horiuchi K, et al. Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol. 2006;12(4):608–611. doi:10.3748/wjg.v12.i4.60816489676
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236. doi:10.1002/hep.2093316250051
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202.14514818
   PubMed Web of Science ®Google Scholar
• Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29(11):1364–1373. doi:10.1007/s00268-005-7829-616240062
   PubMed Web of Science ®Google Scholar
• Dong J, Li W, Zheng Q, et al. CT-guided percutaneous step-by-step radiofrequency ablation for the treatment of carcinoma in the caudate lobe. Medicine (Baltimore). 2005;94(39):e1594. doi:10.1097/MD.0000000000001594
   Google Scholar
• Guo Y, Zhang Y, Huang J, et al. Safety and efficacy of transarterial chemoembolization combined with CT-guided radiofrequency ablation for hepatocellular carcinoma adjacent to the hepatic hilum within milan criteria. J Vasc Interv Radiol. 2016;27(4):487–495. doi:10.1016/j.jvir.2016.01.00226922006
   PubMed Web of Science ®Google Scholar
• Lee LH, Hwang JI, Cheng YC, et al. Comparable outcomes of ultrasound versus computed tomography in the guidance of radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2017;12(1):e0169655. doi:10.1371/journal.pone.016965528068369
   PubMed Web of Science ®Google Scholar
• Cha CH, Lee FT Jr, Gurney JM, et al. CT versus sonography for monitoring radiofrequency ablation in a porcine liver. AJR Am J Roentgenol. 2000;175(3):705–711. doi:10.2214/ajr.175.3.175070510954454
   PubMed Web of Science ®Google Scholar
• Widmann G, Schullian P, Haidu M, Bale R. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol. 2012;35(3):570–580. doi:10.1007/s00270-011-0200-421671150
   PubMed Web of Science ®Google Scholar
• Minami Y, Kudo M, Kawasaki T, et al. Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. J Gastroenterol. 2003;38(11):1066–1070. doi:10.1007/s00535-003-1197-514673724
   PubMed Web of Science ®Google Scholar
• Kondo Y, Yoshida H, Tateishi R, Shiina S, Kawabe T, Omata M. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg. 2008;95(8):996–1004. doi:10.1002/bjs.605818581421
   PubMed Web of Science ®Google Scholar
• Kagawa T 1, Koizumi J, Kojima S, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer. 2010;116(15):3638–3644. doi:10.1002/cncr.2514220564097
   PubMed Web of Science ®Google Scholar
• Scher N, Janoray G, Riet FG, et al. Stereotactic body radiation therapy for hepatocellular carcinoma: results from a retrospective multicentre study. Cancer Radiother. 2019;23(2):104–115. doi:10.1016/j.canrad.2018.07.13830952560
   PubMed Web of Science ®Google Scholar
• Shibata T, Shibata T, Maetani Y, et al. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol. 2004;15(11):1323–1327. doi:10.1097/01.RVI.0000132297.97113.C415525754
   PubMed Web of Science ®Google Scholar
• Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of sectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217(1):119–126. doi:10.1148/radiology.217.1.r00se0211911012432
   PubMed Web of Science ®Google Scholar
• Kang SG, Yoon CJ, Jeong SH, et al. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol. 2009;20(12):1570–1577. doi:10.1016/j.jvir.2009.09.00319879777
   PubMed Web of Science ®Google Scholar
• Kim JW, Kim JH, Won HJ, et al. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs.radiofrequency ablation alone. Eur J Radiol. 2012;81(3):e189–e193. doi:10.1016/j.ejrad.2011.01.12221353417
   PubMed Web of Science ®Google Scholar